Skip to main content
Equibles

DAFNA Capital Management LLC

Position in BCYC — Bicycle Therapeutics PLC

CIK 1389933 LOS ANGELES, CA
Back to BCYC Full portfolio

Position in BCYC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$273,446
-$25,796 QoQ
Shares Held
64,492
0.0% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#41
of 103 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCYC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. BCYC ranks #61 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 562,630 $105,369,346
2 NKTR
Nektar Therapeutics
 318,380 $22,226,107
3 DNLI
Denali Therapeutics Inc.
 739,014 $19,007,440
4 IDYA
IDEAYA Biosciences, Inc.
 497,240 $18,532,134
5 XENE
Xenon Pharmaceuticals Inc.
 250,772 $15,136,597
6 CYTK
Cytokinetics Inc
 171,998 $14,652,509
7 RCUS
Arcus Biosciences, Inc.
 441,829 $13,621,588
8 ASND
Ascendis Pharma A/S
 48,469 $12,927,651

All Filings in BCYC

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $273,446 64,492
2026-03-31 $299,242 64,492
2025-12-31 $456,603 64,492
2025-09-30 $499,168 64,492
2025-06-30 $448,219 64,492
2025-03-31 $685,983 80,799
2024-12-31 $1,691,186 120,799
2024-09-30 $2,765,386 122,200
2024-06-30 $2,473,328 122,200
2024-03-31 $3,042,780 122,200
2023-12-31 $2,209,376 122,200
2023-09-30 $2,454,998 122,200
2023-06-30 $3,118,544 122,200
2023-03-31 $2,599,194 122,200
2022-12-31 $3,617,120 122,200
2022-09-30 $2,842,372 122,200
2022-06-30 $2,201,536 131,200
2022-03-31 $2,334,416 53,200